Literature DB >> 3270332

Sublingual nifedipine in acute severe hypertension.

J H Evans1, N J Shaw, J T Brocklebank.   

Abstract

Sublingual nifedipine was used for the treatment of acute severe hypertension in 12 children with renal disease. An average dose of 0.24 mg/kg was safe and proved effective on most occasions within 30 minutes with a median duration of action of three hours. There were no major adverse effects.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3270332      PMCID: PMC1778952          DOI: 10.1136/adc.63.8.975

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  4 in total

1.  Blood pressure and hormonal responses to sublingual nifedipine in acute childhood hypertension.

Authors:  W Rascher; K E Bonzel; H Ruder; D E Müller-Wiefel; K Schärer
Journal:  Clin Exp Hypertens A       Date:  1986

2.  Emergency treatment of hypertensive crisis with sublingual nifedipine.

Authors:  R Erbel; G Brand; J Meyer; S Effert
Journal:  Postgrad Med J       Date:  1983       Impact factor: 2.401

3.  [Experiences with nifedipine in the treatment of acute hypertension in childhood].

Authors:  H Stopfkuchen; D Schranz; R Ziegler; B K Jüngst
Journal:  Monatsschr Kinderheilkd       Date:  1985-04       Impact factor: 0.323

4.  Nifedipine in hypertensive emergencies.

Authors:  O Bertel; D Conen; E W Radü; J Müller; C Lang; U C Dubach
Journal:  Br Med J (Clin Res Ed)       Date:  1983-01-01
  4 in total
  10 in total

1.  Evaluation of the safety and efficacy of metoprolol infusion for children and adolescents with hypertensive crises: a retrospective case series.

Authors:  Rola Saqan; Hanan Thiabat
Journal:  Pediatr Nephrol       Date:  2017-07-21       Impact factor: 3.714

2.  Rectal nifedipine in acute severe hypertension in young children.

Authors:  M Uchiyama; I Ogawa
Journal:  Arch Dis Child       Date:  1989-04       Impact factor: 3.791

3.  Sublingual nifedipine in acute severe hypertension.

Authors:  R C Hatton; M L Marcadis
Journal:  Arch Dis Child       Date:  1989-04       Impact factor: 3.791

4.  Clinical trial of extended-release felodipine in pediatric essential hypertension.

Authors:  Howard Trachtman; Rachel Frank; John D Mahan; Ronald Portman; Irene Restaino; Tej K Matoo; Conrad Tou; Michael Klibaner
Journal:  Pediatr Nephrol       Date:  2003-04-17       Impact factor: 3.714

Review 5.  A review of calcium channel antagonists in the treatment of pediatric hypertension.

Authors:  Shobha Sahney
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

Review 6.  The management of hypertensive emergencies in children after stem cell transplantation.

Authors:  D G Horn; M N Trame; G Hempel
Journal:  Int J Clin Pharm       Date:  2011-03-12

Review 7.  Comparative tolerability profile of hypertensive crisis treatments.

Authors:  E Grossman; A N Ironi; F H Messerli
Journal:  Drug Saf       Date:  1998-08       Impact factor: 5.606

8.  The safety and use of short-acting nifedipine in hospitalized hypertensive children.

Authors:  Verna Yiu; Elaine Orrbine; Rhonda J Rosychuk; Peter MacLaine; Paul Goodyer; Colette Girardin; Manjula Gowrishankar; Malcolm Ogborn; Julian Midgley; Guido Filler; Frances Harley
Journal:  Pediatr Nephrol       Date:  2004-03-31       Impact factor: 3.714

Review 9.  Pharmacological management of hypertension in paediatric patients. A comprehensive review of the efficacy, safety and dosage guidelines of the available agents.

Authors:  K Miller
Journal:  Drugs       Date:  1994-12       Impact factor: 9.546

Review 10.  Evaluation and treatment of hypertensive crises in children.

Authors:  Deborah R Stein; Michael A Ferguson
Journal:  Integr Blood Press Control       Date:  2016-03-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.